
Aripiprazole LAI use in LBD-related symptoms shows small, inconsistent improvements with notable safety concerns, suggesting the need for caution in its application.
safety, LBD, aripiprazole, treatment, Lewy Body Dementia, neurology, effectiveness, pharmacology, long-acting injectable
safety, LBD, aripiprazole, treatment, Lewy Body Dementia, neurology, effectiveness, pharmacology, long-acting injectable
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
